Literature DB >> 34899046

Diagnosis and Therapy of Female Genital Malformations (Part 2). Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/052, May 2019).

Peter Oppelt1, Helge Binder1, Jacques Birraux2, Sara Brucker3, Irene Dingeldein4, Ruth Draths5, Felicitas Eckoldt6, Ulrich Füllers7, Olaf Hiort8, Dorit Hoffmann9, Markus Hoopmann3, Jürgen Hucke10, Matthias Korell11, Maritta Kühnert12, Barbara Ludwikowski13, Hans-Joachim Mentzel14, Dan Mon OʼDey15, Katharina Rall3, Michael Riccabona16, Stefan Rimbach17, Norbert Schäffeler18, Sandra Shavit19, Raimund Stein20, Boris Utsch21, Rene Wenzl22, Peter Wieacker23, Mazen Zeino24.   

Abstract

Objectives Female genital malformations may be present in the form of individual entities, they may involve neighboring organs or they may occur in the context of complex syndromes. Given the anatomical structures of the vulva, vagina, uterus and uterine appendages, the clinical picture of malformations varies greatly. Methods This S2k-guideline was developed by representative members from different medical specialties and professions as part of the guidelines program of the DGGG, SGGG and OEGGG. The recommendations and statements were developed and voted on using a structured consensus process with neutral moderation. Recommendations This guideline is the first comprehensive summary of female genital malformations from infancy to adulthood which covers clinical examinations, diagnostic workups and treatment options. Additional chapters have been included on complex urogenital malformations, vascular malformations, psychosomatic care, and tumor risk. Thieme. All rights reserved.

Entities:  

Keywords:  bicornuate uterus; genital malformations; guideline; malformations of the uterine adnexa; septate uterus; subseptate uterus; unicornuate uterus; uterine vascular malformations

Year:  2021        PMID: 34899046      PMCID: PMC8654518          DOI: 10.1055/a-1471-4988

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  8 in total

1.  The effect of a group programme on women with the Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  P T Weijenborg; M M ter Kuile
Journal:  BJOG       Date:  2000-03       Impact factor: 6.531

2.  Renal and urological abnormalities occurring with Mullerian anomalies.

Authors:  Margaret A Hall-Craggs; Alex Kirkham; Sarah M Creighton
Journal:  J Pediatr Urol       Date:  2011-11-29       Impact factor: 1.830

3.  Female genital malformations and their associated abnormalities.

Authors:  Peter Oppelt; Meike von Have; Mareike Paulsen; Pamela L Strissel; Reiner Strick; Sara Brucker; Diethelm Wallwiener; Matthias W Beckmann
Journal:  Fertil Steril       Date:  2006-11-27       Impact factor: 7.329

Review 4.  Congenital malformations of the genital tract and their management.

Authors:  D Keith Edmonds
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2003-02       Impact factor: 5.237

5.  A randomized controlled trial of a cognitive-behavioural group intervention versus waiting-list control for women with uterovaginal agenesis (Mayer-Rokitansky-Küster-Hauser syndrome: MRKH).

Authors:  J G Heller-Boersma; U H Schmidt; D K Edmonds
Journal:  Hum Reprod       Date:  2007-06-21       Impact factor: 6.918

Review 6.  The presentation and management of complex female genital malformations.

Authors:  Pedro Acién; Maribel Acién
Journal:  Hum Reprod Update       Date:  2015-11-03       Impact factor: 15.610

Review 7.  A Review of Mullerian Anomalies and Their Urologic Associations.

Authors:  Charlotte Q Wu; Krista J Childress; Elizabeth J Traore; Edwin A Smith
Journal:  Urology       Date:  2020-05-06       Impact factor: 2.649

Review 8.  Clinical and genetic aspects of Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  Susanne Ledig; Peter Wieacker
Journal:  Med Genet       Date:  2018-02-21
  8 in total
  1 in total

Review 1.  Clinical spectrum of female genital malformations in prenatal diagnosis.

Authors:  Michael R Mallmann; Ulrich Gembruch
Journal:  Arch Gynecol Obstet       Date:  2022-02-27       Impact factor: 2.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.